AIM
CMD

Aigen Investment Management’s Cantel Medical Corporation CMD Stock Holding History

Aigen Investment Management’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-13,826
Closed -$1.1M – 812
2021
Q1 		$1.1M Buy
13,826
+10,287
+291% +$803K 0.15% 159
2020
Q4 		$279K Buy
+3,539
New +$208K 0.04% 575
2020
Q3 		– Sell
-18,744
Closed -$829K – 1192
2020
Q2 		$829K Buy
18,744
+12,014
+179% +$448K 0.11% 306
2020
Q1 		$242K Buy
6,730
+5,531
+461% +$314K 0.03% 647
2019
Q4 		$85K Buy
+1,199
New +$87K 0.01% 715

Aigen Investment Management's CMD Position: Q2 2021 in Review

Aigen Investment Management sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 13,826 shares — an estimated $1.1M sold.

Aigen Investment Management first reported a position in CMD in Q4 2019 and held it in 5 quarters. The position peaked at $1.1M in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

  • Aigen Investment Management reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
  • Aigen Investment Management sold 13,826 Cantel Medical Corporation shares in Q2 2021, an estimated $1.1M.
  • Aigen Investment Management first reported a position in Cantel Medical Corporation in Q4 2019 and held it in 5 quarters.
  • Aigen Investment Management's Cantel Medical Corporation position peaked at $1.1M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on Aigen Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.